Literature DB >> 30660824

The cardioprotective properties and the involved mechanisms of NaoXinTong Capsule.

Jihong Han1, Hao Tan2, Yajun Duan3, Yuanli Chen3, Yan Zhu4, Buchang Zhao5, Yong Wang5, Xiaxiao Yang6.   

Abstract

NaoXinTong Capsule (NXT), a prescribed traditional Chinese medicine, is made up of 16 natural herbal materials with more than 200 identified bioactive compounds. Multiple protective effects of NXT on cardiovascular diseases including atherosclerosis, coronary artery disease, acute coronary syndrome, coronary microembolization, myocardial infarction, ischemic stroke and ischemia-reperfusion injury, have been reported by both clinical and basic studies. Biologically, these cardioprotective effects can be correlated to the actions of NXT on inflammation, apoptosis, oxidative stress, neovascularization, insulin sensitivity and lipid/glucose metabolism. NXT alone or in combination with the conventional interventions has been demonstrated potent therapeutic effects on cardiovascular diseases without causing significant adverse events, like the major bleeding. Compared with the conventional drugs, patients have a good tolerance and little resistance to NXT treatment. With the data and evidence reported from lab benches to clinical beds, we will update the cardioprotective properties of NXT and the involved mechanisms in this review. We hope the information provided in this review can help readers to better understand the insights for the long practice of this traditional Chinese medicine, and offer fresh perspectives.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardioprotective effects; Cardiovascular disease; NaoXinTong Capsule; Traditional Chinese medicine

Mesh:

Substances:

Year:  2019        PMID: 30660824     DOI: 10.1016/j.phrs.2019.01.024

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  13 in total

Review 1.  Meta-Analysis of Naoxintong Capsule for Patients with Vascular Dementia.

Authors:  Li Li; Yawei Zheng; Jinjing Bao; Yandong Zhao; Qiuchi Zhang; Wenlei Li; Minghua Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-06       Impact factor: 2.650

2.  Analysis of Clinical Efficacy of Traditional Chinese Medicine in Recovery Stage of Stroke: A Systematic Review and Meta-Analysis.

Authors:  Xue Zhang; Xiao-Fei Zhang; Lin Wang; Dong-Yan Guo; Jia-Min Zhang; Yong-Gang Chen; Zhi-Chao Wang; Li-Shan Pei; Jiang-Xue Chen; Ya-Jun Shi; Jun-Bo Zou
Journal:  Cardiovasc Ther       Date:  2020-09-19       Impact factor: 3.023

3.  Efficacy and safety of Naoxintong capsule for treating chronic stable angina: study protocol for a randomized controlled trial.

Authors:  Gao Huanjia; Cai Hairong; Zhuang Jieqin; Dai Xingzhen; Fu Xue; Zhang Weizhang; Chen Bojun
Journal:  Trials       Date:  2021-05-10       Impact factor: 2.279

4.  Integrated metabolomics and gut microbiome to the effects and mechanisms of naoxintong capsule on type 2 diabetes in rats.

Authors:  Zenghao Yan; Hao Wu; Haokui Zhou; Shuo Chen; Yan He; Weijian Zhang; Taobin Chen; Hongliang Yao; Weiwei Su
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

5.  Naoxintong Capsule Inhibits the Development of Cardiovascular Pathological Changes in Bama Minipig Through Improving Gut Microbiota.

Authors:  Wei-Jian Zhang; Wei-Wei Su; Pei-Bo Li; Hong-Yu Rao; Qing-Wei Lin; Xuan Zeng; Tao-Bin Chen; Zeng-Hao Yan; Hong Liu; Hong-Liang Yao
Journal:  Front Pharmacol       Date:  2019-10-03       Impact factor: 5.810

6.  Efficacy and safety of traditional Chinese patent medicine on carotid artery atherosclerosis in adults: A network meta-analysis protocol.

Authors:  Huiqing Sun; Wei Qu; Guangjia Chen; Xiaonan Sun; Deqing Zhang; Shichuan Shao
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

7.  Screening of Potential Thrombin and Factor Xa Inhibitors from the Danshen-Chuanxiong Herbal Pair through a Spectrum-Effect Relationship Analysis.

Authors:  Xu Wang; Dai-Yan Zhang; Shi-Jun Yin; Hui Jiang; Min Lu; Feng-Qing Yang; Yuan-Jia Hu
Journal:  Molecules       Date:  2021-12-01       Impact factor: 4.411

Review 8.  Atheroprotective Effects and Mechanisms of Postmarketing Chinese Patent Formulas in Atherosclerosis Models: A Systematic Review.

Authors:  Shiqi Chen; Xiaoxiao Wu; Tong Li; Yang Li; Baofu Wang; Weiting Cheng; Yu Teng; Jingjing Yang; Hui Meng; Lei Wang; Ziwen Lu; Yangyang Jiang; Yahong Wang; Mingjing Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-27       Impact factor: 2.629

9.  Protective effects of Naoxintong capsule alone and in combination with ticagrelor and atorvastatin in rats with Qi deficiency and blood stasis syndrome.

Authors:  Wei-Jian Zhang; Wei-Wei Su; Qing-Wei Lin; Yan He; Zeng-Hao Yan; Yong-Gang Wang; Pei-Bo Li; Hao Wu; Hong Liu; Hong-Liang Yao
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

10.  Comparison of Buyang Huanwu granules and Naoxintong capsules in the treatment of stable angina pectoris: rationale and design of a randomized, blinded, multicentre clinical trial.

Authors:  Yu Wang; Yuhan Xu; Ling Zhang; Shuwei Huang; Liping Dou; Jiehong Yang; Wei Fu; Peng Zhou; Haitong Wan
Journal:  Trials       Date:  2022-01-21       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.